Advertisement

Topics

German Pharma and Biotech Gang Up on NASH in an Exciting Collaboration

09:04 EST 8 Nov 2017 | Labiotech.eu

Boehringer Ingelheim’s fight against liver disease is taking shape, having agreed on a partnership with RNA pioneer MiNA Therapeutics to fight NASH. British biotech, MiNA Therapeutics, has announced a partnership with pharma giant Boehringer Ingelheim to focus on developing compounds to treat fibrotic liver ...

This awesome article German Pharma and Biotech Gang Up on NASH in an Exciting Collaboration appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: German Pharma and Biotech Gang Up on NASH in an Exciting Collaboration

NEXT ARTICLE

More From BioPortfolio on "German Pharma and Biotech Gang Up on NASH in an Exciting Collaboration"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Hepatology
Hepatology is the study of liver, gallbladder, biliary tree, and pancreas, and diseases associated with them. This includes viral hepatitis, alcohol damage, cirrhosis and cancer. As modern lifestyles change, with alcoholism and cancer becoming more promi...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...